2024 CIHR-CTS Mid-Career Lecturer in Respiratory Sciences
Congratulations to Dr. Maziar Divangahi, who has been named the 2024 CIHR-CTS Mid-Career Lecturer in Respiratory Sciences for 2024.
Maziar Divangahi
View his faculty profile here: Maziar Divangahi, PhD
Professor, Department of Medicine, McGill University
Associate Director, Meakins-Christie Laboratories
Research Theme: Host defense against pulmonary pathogens; regulation of death program in macrophages
Keywords: innate and adaptive immunity • influenza virus • mycobacterium tuberculosis • cell death program
View Maziar Divangahi’s recent posts and news below.
Spring 2023 Student Awards
Congratulations to the 2023 recipients of FRQS and CIHR studentship and fellowship awards! We wish you much success!
RESP Research Day Oral and Poster Presenter Winners – 2023
Congratulations to all of our oral and poster presenter winners from the 2023 Respiratory Research Day.
MI4 Seed Fund Grant Results – MCL Faculty Receive Funding
Irah King and Maziar Divangahi receive funding from the MI4 Seed Grant Competition to research solutions against microbial threats.
2023 MUHC Foundation MCI Innovation Grant Awards
Congratulations to the 2023 MUHC Foundation MCI Innovation Grants competition winners, Jonathon Campbell, Maziar Divangahi, Nicole Ezer, Simon Rousseau, Sushmita Pamidi, Salman Qureshi and Bryan Ross!
Prenatal Programming of Alveolar Macrophages by Neutrophils Needed for Lung Health
Publication in Nature by Maziar Divangahi and colleagues shows that the production of eicosanoids by neutrophils is required for reprogramming alveolar macrophages
2022 CODE LiFE Research Awards: Celebrating Innovation Through Philanthropy
Maziar Divangahi is a recipient of the Montreal General Hospital Foundation’s 2022 Code Life Research Awards
Spring 2022 Student Awards
Congratulations to the recipients of FRQS and CIHR studentship and fellowship awards! We wish you much success!
BCG Vaccine Provides Protection Against Influenza Virus but Not SARS-CoV-2
Maziar Divangahi and his research team are surprised to discover that BCG provides protection against respiratory infections but not SARS-CoV-2.
International Rare Disease Day: Alex’s Story
At the Meakins-Christie Laboratories, we care about rare diseases. Read Alexandre Grant’s interview on his rare disease diagnosis.